CollPlant Biotechnologies New
Earnings Surprise
Analysts estimated CLGN earnings of $-0.19 per share this quarter (Q4). CLGN's actual earnings were $-0.26 per share.
CLGN EPS surprise of -34.16%Analysts estimated CLGN earnings of $0.16 per share this quarter (Q3). CLGN's actual earnings were $-0.27 per share.
CLGN EPS surprise of -158.56%Analysts estimated CLGN earnings of $-0.14 per share this quarter (Q2). CLGN's actual earnings were $-0.28 per share.
CLGN EPS surprise of -96.08%Analysts estimated CLGN earnings of $-0.04 per share this quarter (Q1). CLGN's actual earnings were $-0.13 per share.
CLGN EPS surprise of -218.63%Analysts estimated CLGN earnings of $-0.28 per share this quarter (Q4). CLGN's actual earnings were $-0.34 per share.
CLGN EPS surprise of -21.21%Analysts estimated CLGN earnings of $-0.29 per share this quarter (Q3). CLGN's actual earnings were $-0.38 per share.
CLGN EPS surprise of -30.72%Analysts estimated CLGN earnings of $-0.28 per share this quarter (Q2). CLGN's actual earnings were $-0.37 per share.
CLGN EPS surprise of -34.35%Analysts estimated CLGN earnings of $-0.07 per share this quarter (Q4). CLGN's actual earnings were $-0.24 per share.
CLGN EPS surprise of 236.13%Analysts estimated CLGN earnings of $-0.13 per share this quarter (Q3). CLGN's actual earnings were $-0.38 per share.
CLGN EPS surprise of 186.58%